Advancing Pharmacogenomics through Biobanks, Real-World Data, and Clinical Implementation

Thursday, September 11, 2025, 12:00 PM - 3:00 PM

1. Describe how large-scale biobanks are advancing pharmacogenomic discovery and enabling more inclusive genomic research.
2. Identify the relationship between pharmacogenomic variation, such as CYP2D6 genotype and inhibitor status, and real-world clinical outcomes.
3. Evaluate the integration of electronic health records (EHRs) and biobank-linked genomic data in pharmacogenomic translational research.
4. Assess real-world implications of genome-guided prescribing.

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this for a maximum of 1.50 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ACPE - Accreditation Council for Pharmacy Education (1.50 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.

Thursday, September 11, 2025